Quinn Opportunity Partners LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$400,000
-16.7%
25,100
+8.7%
0.05%
-34.6%
Q4 2017$480,000
-16.5%
23,100
-42.4%
0.08%
-13.3%
Q3 2017$575,000
-17.3%
40,099
-0.2%
0.09%
-21.7%
Q2 2017$695,000
-60.7%
40,199
-74.9%
0.12%
-71.8%
Q1 2017$1,768,000
-31.7%
160,299
-10.1%
0.41%
-47.8%
Q4 2016$2,589,000
+0.0%
178,299
+81.2%
0.78%
-21.2%
Q1 2016$2,588,00098,4000.99%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2016
NameSharesValueWeighting ↓
Bruce & Co., Inc. 850,000$6,987,0002.38%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders